Related Experiment Video
Updated: Nov 9, 2025

Visualizing the Conformational Dynamics of Membrane Receptors Using Single-Molecule FRET
Published on: August 17, 2022
Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics
Abdullahi Ibrahim Uba1, Nicolas Scorese2, Emily Dean2
1Complex Systems Division, Beijing Computational Science Research Center, Beijing 100193, China.
Abstract:
The corticotropin-releasing factor receptor type 1 (CRF1R), a member of class B G-protein-coupled receptors (GPCRs), is a good drug target for treating depression, anxiety, and other stress-related neurodisorders. However, there is no approved drug targeting the CRF1R to date, partly due to inadequate structural information and its elusive activation mechanism. Here, by use of the crystal structures of its transmembrane domain (TMD) and the N-terminal extracellular domain (ECD) as a template, a full-length homology model of CRF1R was built and its complexes with peptide agonist urocortin 1 or small molecule antagonist CP-376395 were subjected to all-atom molecular dynamics simulations. We observed well preserved helical contents in the TMD through simulations, while the transmembrane (TM) helices showed clear rearrangements. The TM rearrangement is especially pronounced for the TM6 in the agonist-bound CRF1R system. The observed conformational changes are likely due to breakage of interhelical/inter-regional hydrogen bonds in the TMD. Dynamical network analysis identifies communities with high connections to TM6. Simulations reveal three key residues, Y3566.53, Q3847.49, and L3957.60, which corroborate experimental mutagenesis data, implying the important roles in the receptor activation. The observed large-scale conformational changes are related to CRF1R activation by agonist binding, providing guidance for ligand design.
Insights
Researchers modeled the corticotropin-releasing factor receptor type 1 (CRF1R) to understand its activation mechanism. Molecular dynamics simulations revealed key conformational changes and residues crucial for CRF1R function, guiding new drug development for stress disorders.
Area of Science:
- Pharmacology
- Biochemistry
- Computational Biology
Background:
- The corticotropin-releasing factor receptor type 1 (CRF1R) is a class B G-protein-coupled receptor (GPCR) targeted for treating depression, anxiety, and stress-related disorders.
- Current limitations in drug development for CRF1R stem from insufficient structural data and an unclear activation mechanism.
Purpose of the Study:
- To elucidate the activation mechanism of CRF1R by constructing a full-length homology model.
- To investigate the conformational dynamics of CRF1R upon binding with an agonist (urocortin 1) and an antagonist (CP-376395) using molecular dynamics simulations.
Main Methods:
- Homology modeling of the full-length CRF1R using crystal structures of its transmembrane (TMD) and extracellular domains (ECD).
- All-atom molecular dynamics simulations of CRF1R complexes with urocortin 1 and CP-376395.
- Dynamical network analysis to identify key residues and communities involved in receptor activation.
Main Results:
- Transmembrane domain (TMD) helical structures remained stable, but transmembrane (TM) helices underwent significant rearrangements, particularly TM6 in the agonist-bound state.
- Conformational changes were attributed to the disruption of interhelical hydrogen bonds within the TMD.
- Identified three critical residues (Y356, Q384, L395) involved in receptor activation, consistent with experimental mutagenesis data.
Conclusions:
- Agonist binding induces large-scale conformational changes in CRF1R, providing insights into its activation mechanism.
- The identified key residues and observed dynamics offer valuable guidance for the rational design of novel CRF1R-targeting ligands.
- Understanding CRF1R dynamics is crucial for developing effective therapeutics for stress-related neuropsychiatric disorders.
More Related Videos
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Receptor Tyrosine Kinases